Skip to main content
Fig. 3 | Cellular & Molecular Biology Letters

Fig. 3

From: Therapeutic utility of mesenchymal stromal cell (MSC)-based approaches in chronic neurodegeneration: a glimpse into underlying mechanisms, current status, and prospects

Fig. 3

Clinical trials based on mesenchymal stromal cell (MSC) therapy in common neurodegenerative diseases registered on ClinicalTrials.gov (April 2022). The schematic demonstrates clinical trial according to condition (A), phase (B), MSC source (C), study location (D), study status (E), and administration rote (F)

Back to article page

Cellular & Molecular Biology Letters

ISSN: 1689-1392

Contact us